Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  60250-04 Neonatal DES Induced Uterine Dysplasia/Neoplasia End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
60250-04 Neonatal DES Induced Uterine Dysplasia/Neoplasia



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 60250-04 NEONATAL DES INDUCED UTERINE DYSPLASIA/NEOPLASIA

  3. Project Focus: EXPOSURE ASSESSMENT

  4. Description: When hamsters are healed neonatally with the synthetic estrogen, dethylstibestrol (UES), their uteri consistent exhibita severe hyperplastic/neoplastic response to estrogen in adulthood. One of two alternatives working hypotheses shouldexplain this phenomenon: 1) Direct Action The cellular physiology and/or composition of the neonatal hamster uterusis directly and permanently altered by the DES insult such that the adult organism overall proliferative response toestrogen becomes atypical, or 2) Indirect Action Uterotrophic activity is mediated by estrogen primarily through or inconjunction with other unidentified factors, and neonatal DES treatment permanently alters the level or functionalactivity of such factors. Testing these hypotheses will begin (Specific Aim #1) by monitoring the morphogenesis ofneonatal uteri from control and DES healed donot animals that are transplanted into the contralateral cheek pouches ofcontrol and DES-treated mature hosts that are ovariectomized and estrogen-replaced. To confirm and extend thefindings (Specific Aim #2), homotypic and heterotypic recombination of uterine stroma and epithelium from control andDES-treated animals will be performed and their morphogenesis will be studied: a) in vitro using media supplementedwith uterine tissue extracts and/or serum from the same host groups used in Specific Aim #1 and b) in vivo (within thecheek pouch) using the same host groups as in Specific Aim #1. Because this combination of approaches relies on few,if any, a prior assumptions and accommodates both in vivo and in vitro observations, firm conclusions should be reachedabout which alternative hypothesis is most valid. Lastly (Specific Aim #3), we will test whether altered expression ofknown regulatory genes is involved in the atypical estrogen responsiveness of adult uteri in neonatally DES treatedhamsters. We will begin with the c-myc c-tos and c-jun proto- oncogenes plus the p53 anti-oncogene. Their expressionwill be probed at the RVA and protein level as well as at the whole organ and cell specific level using Northern blotanalysis, in situ hybridization, immunoprecipitation/ Western blot analysis and immunohistochemistry. Together thesestudies should contribute significantly to our long-term objectives of 1) understanding the basic mechanisms wherebyestrogen regulates uterine growth and morphogenesis and 2) identifying mechanistic alterations that are responsible fordegeneration of this process to the unregulated neoplastic state.

  5. References:

  6. Category: MODELS

  7. Subcategory: BASIC RESEARCH

  8. Keywords for Experimental System/Species: LABORATORY STUDY, IN VIVO, IN VITRO

  9. Keywords for Experimental Endpoints: PHYSIOLOGY, GROWTH

  10. Chemical Agents: ESTROGEN, DETHYLSTIBESTROL (DES)

  11. Performing Institution: WICHITA STATE UNIVERSITY

  12. Contact: CONTACT PERSON: ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301- 496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer